Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Topical Imiquimod Versus Conization to Treat Cervical Intraepithelial Neoplasia (ITIC2)

This study has been terminated.
(poor recruitment)
Sponsor:
Collaborators:
Medical University of Graz
Medical University Innsbruck
Krankenhaus Barmherzige Schwestern Linz
Salzburger Landeskliniken
Information provided by (Responsible Party):
Stephan Polterauer, Medical University of Vienna
ClinicalTrials.gov Identifier:
NCT01283763
First received: January 21, 2011
Last updated: October 30, 2016
Last verified: October 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: January 2018
  Estimated Primary Completion Date: September 2017 (Final data collection date for primary outcome measure)